What will be the next COVID-19? And perhaps more importantly, will all our preparation be appropriate for the direct confrontation of the next human disaster? If COVID-19 taught us anything, it was less about the stockpiles of personal protective equipment and more about our ability to react and change both strategies and tactics as new information became available. The virus was in the air. But also, so was change.
The year 2020 was certainly complex—in many ways. Complexity was met with the demands of rapid action and the results were both innovation and confusion. COVID-19 compressed years of science, pharmaceutical development, technological advances and clinical practice into just months. And then, layer the moral imperative of action into this equation. And beyond the clinicians and scientists, everyday citizens were thrust into making decisions that put at risk so many things, from lives to businesses.
What did we learn from 2020? In a word, it comes down to agility. It seemed that almost every day in 2020 provided new data, insights, and guidelines that helped informed clinical practice and everyday life. For physicians, this pushed them away from the clinical comfort zone into more of a “risk/reward” posture.
COVID-19 admissions and hospital census resulted in logistical and emotional pressures that took a significant toll on both patient and practitioner. For citizens, it forced us all to reassess the very fundamental aspects of life unfolding along a less rational and informed perspective, but in the "real time" or even the "compressed time" of the pandemic. The essential tool—for both citizen and clinician—was agility in the face of viral and informational mutation.
John is the #1 global influencer in digital health and generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change in the health / tech marketplaces. He is also a member of the Google Health Advisory Board, pens HEALTH CRITICAL for Forbes--a top global blog on health & technology and THE DIGITAL SELF for Psychology Today—a leading blog focused on the digital transformation of humanity. He is also on the faculty of Exponential Medicine. John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of advertising,” a process where strategy and creativity work together for superior marketing. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on acute myocardial infarction, ventricular arrhythmias and sudden cardiac death.